An international team of researchers led by Dr. Eleanor Fish, Scientist Emeritus at the Toronto General Hospital Research Institute, UHN, and professor in the University of Toronto‘s Department of Immunology, has shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients.
According to the new study, published Friday in Frontiers in Immunology, treatment with interferon(IFN)- a2b may significantly accelerate virus clearance and reduce levels of inflammatory proteins in COVID-19 patients.
The research team found that treatment with this drug, which has been used clinically for many years, significantly reduced the duration of detectable virus in the upper respiratory tract, on average by about seven days. It also reduced blood levels of interleukin(IL)-6 and C-reactive protein (CRP), two inflammatory proteins found in COVID-19 patients.
Dr. Fish says the research team considered IFN-a therapy for COVID-19 after they demonstrated interferon provided therapeutic benefit during the SARS outbreak of 2002 and 2003.
“Rather than developing a virus-specific antiviral for each new virus outbreak, I would argue that we should consider interferons as the ‘first responders’ in terms of treatment,” says Dr. Fish.
“Interferons have been approved for clinical use for many years, so the strategy would be to ‘repurpose’ them for severe acute virus infections.”
Boosting a natural defence mechanism
Interferons are a group of signaling proteins released by the human body in response to all viruses. As Dr. Fish explains, they are a “first line of defence.”
They target different stages of a virus’s life cycle, inhibiting them from multiplying. They also boost an immune response by activating different immune cells to clear an infection. Some viruses, however, can block this natural defense mechanism.
“But it is possible to override this block. If a virus blocks interferon production, then treating with interferon can offset this.”
The researchers conducted this exploratory study on a group of 77 patients with COVID-19 in Wuhan, China. These patients were admitted to Union Hospital, Tongii Medical College, between January 16 and February 20, 2020. They represented moderate cases of the disease as none of the patients required intensive care or prolonged oxygen supplementation or intubation.
Despite the study’s limitations of a small, non-randomized group of patients, the work provides several important and novel insights into COVID-19 disease, notably that treatment with IFN-a2b can accelerate viral clearance from the upper respiratory tract and also reduce circulating levels of inflammatory factors that are associated with severe COVID-19.
Dr. Fish says a randomized clinical trial is a crucial next step. According to her, a clinical trial with a larger group of infected patients who are randomized to treatment or placebo would further this research.
In the meantime, the findings from this study are the first to suggest therapeutic efficacy of IFN-a2b as an available antiviral intervention for COVID-19, which may also benefit public health measures by shortening the duration of viral clearance and therefore slowing the tide of the pandemic.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Recovery of COVID-19 patients
- Media Itching for Second Wave of COVID-19on June 23, 2020 at 12:02 pm
Likely for political reasons, the media has identified Florida and its societal reopening as the leading edge of a second wave.
- 36,921 patients presumed to be recovered across NCon June 23, 2020 at 11:49 am
NORTH CAROLINA (WNCT) The estimated number of patients presumed to be recovered from symptoms from COVID-19 is 36,921. North Carolina Department of Health and Human Services (NCDHHS) estimates a ...
- As COVID-19 cases rise, these are the symptoms to look out for. They include diarrhea and nausea.on June 23, 2020 at 11:31 am
What's behind the rise in COVID-19 cases? As the number of coronavirus cases continues to rise in many parts of the country, health officials say it's important to know what symptoms to look out for.
- How a V-shaped economic recovery could happenon June 23, 2020 at 11:09 am
Abrupt events like the COVID-19 shutdown or a financial crisis tend to weed out weak businesses, like Hertz, which borrowed excessively when the economy was expanding but never really turned decent ...
- COVID-19 threat an ongoing challenge for cancer patientson June 23, 2020 at 10:58 am
Monica Iparrea was just starting to feel “almost normal” when the threat of the novel coronavirus took hold. Diagnosed with breast cancer in late 2019, she has experienced the pandemic threat as an ...
Go deeper with Google Headlines on:
Recovery of COVID-19 patients
Go deeper with Bing News on:
- Governor Abbott, DSHS Sending Antiviral Drug Remdesivir To Dallas, Fort Worth Metro Areaon June 23, 2020 at 11:03 am
After saying this week that COVID-19 is spreading at "unacceptable rate" and must be stopped, Texas Governor Greg Abbott announced that he along with the Texas Department of State Health Services "is ...
- Additional Cases Of Antiviral Drug Remdesivir Distributed to DFW Metroplex for COVID-19 Treatmentson June 23, 2020 at 10:39 am
Governor Greg Abbott has announced that the Texas Department of State Health Services will distribute 120 additional cases of the antiviral drug remdesivir to 37 hospitals across the Dallas-Fort Worth ...
- DSHS distributing 13 additional cases of antiviral drug to 8 East Texas hospitalson June 23, 2020 at 9:39 am
AUSTIN, Texas (News Release) - - Governor Greg Abbott today announced that the Texas Department of State Health Services (DSHS) is distributing 13 additional cases of the antiviral drug remdesivir to ...
- Gilead to buy 49.9% stake in cancer drug developer for $275 millionon June 23, 2020 at 9:07 am
Inc said on Tuesday it would buy a 49.9% stake in privately held Pionyr Immunotherapeutics Inc for $275 million, strengthening its cancer portfolio by securing access to two promising drugs. The ...
- Additional cases of antiviral drug remdesivir to be distributed in Corpus Christion June 23, 2020 at 9:00 am
CORPUS CHRISTI, Texas — As part of the largest round of distribution state-wide, Governor Greg Abbott announced on Tuesday morning that the Texas Department of State Health Services (DSHS) is ...